Results 1 to 10 of about 19,108 (217)

Myostatin and the Heart

open access: yesBiomolecules, 2023
Myostatin (growth differentiation factor 8) is a member of the transforming growth factor-β superfamily. It is secreted mostly by skeletal muscles, although small amounts of myostatin are produced by the myocardium and the adipose tissue as well ...
Małgorzata Knapp   +2 more
doaj   +4 more sources

Myostatin Orchestrates miR-124-Mediated Epigenetic Silencing of ITGB1 to Suppress Skeletal Muscle Growth [PDF]

open access: yesBiomolecules
Although myostatin is a well-established inhibitor of myogenesis, its downstream mediators remain poorly characterized. This study identified integrin β1 (ITGB1), an integrin family member, as a novel mediator in myostatin signaling.
Qi Chen   +8 more
doaj   +2 more sources

Healthy Community-Living Older Men Differ From Women in Associations Between Myostatin Levels and Skeletal Muscle Mass

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2018
Background Myostatin is a negative regulator of muscle growth but the relationship between serum myostatin levels and muscle mass is unclear. This study investigated the association between serum myostatin levels and skeletal muscle mass among healthy ...
Liang-Kung Chen   +2 more
exaly   +2 more sources

A novel splice variant of the human MSTN gene encodes a myostatin‐specific myostatin inhibitor

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2023
Background Myostatin, encoded by the MSTN gene comprising 3 exons, is a potent negative regulator of skeletal muscle growth. Although a variety of myostatin inhibitors have been invented for increasing muscle mass in muscle wasting diseases, no effective
Kazuhiro Maeta   +3 more
doaj   +1 more source

Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. [PDF]

open access: yesPLoS ONE, 2010
Myostatin is well established as a negative regulator of skeletal muscle growth, but its role in the heart is controversial. Our goal in this study was to characterize myostatin regulation following cardiomyocyte stress and to examine the role of ...
Lawrence T Bish   +3 more
doaj   +1 more source

Signals of Ezh2, Src, and Akt Involve in myostatin-Pax7 pathways regulating the myogenic fate determination during the sheep myoblast proliferation and differentiation. [PDF]

open access: yesPLoS ONE, 2015
Myostatin and Pax7 have been well documented individually, however, the mechanism by which Myostatin regulates Pax7 is seldom reported. Here, based on muscle transcriptome analysis in Texel (Myostatin mutant) and Ujumqin (wild type) sheep across the five
Caihong Wei   +9 more
doaj   +1 more source

Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice. [PDF]

open access: yesPLoS ONE, 2010
Myostatin inhibition is a promising therapeutic strategy to maintain muscle mass in a variety of disorders, including the muscular dystrophies, cachexia, and sarcopenia.
Kevin J Morine   +5 more
doaj   +1 more source

Regulation of Myostatin on the Growth and Development of Skeletal Muscle

open access: yesFrontiers in Cell and Developmental Biology, 2021
Myostatin (MSTN), a member of the transforming growth factor-β superfamily, can negatively regulate the growth and development of skeletal muscle by autocrine or paracrine signaling.
Ming-Ming Chen   +4 more
doaj   +1 more source

Decreased myostatin in response to a controlled DASH diet is associated with improved body composition and cardiometabolic biomarkers in older adults: results from a controlled-feeding diet intervention study

open access: yesBMC Nutrition, 2022
Background Elevated concentrations of myostatin inhibit muscle growth, function and strength. Myostatin is a mediator of sarcopenia and is associated with insulin resistance.
Cydne A. Perry   +2 more
doaj   +1 more source

Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice. [PDF]

open access: yesPLoS ONE, 2011
The marked hypermuscularity in mice with constitutive myostatin deficiency reduces fat accumulation and hyperglycemia induced by high-fat feeding, but it is unclear whether the smaller increase in muscle mass caused by postdevelopmental loss of myostatin
Kerri Burgess   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy